These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 19414634)

  • 21. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor-23 and cardiovascular events in CKD.
    Scialla JJ; Xie H; Rahman M; Anderson AH; Isakova T; Ojo A; Zhang X; Nessel L; Hamano T; Grunwald JE; Raj DS; Yang W; He J; Lash JP; Go AS; Kusek JW; Feldman H; Wolf M;
    J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T.
    Negishi K; Kobayashi M; Ochiai I; Yamazaki Y; Hasegawa H; Yamashita T; Shimizu T; Kasama S; Kurabayashi M
    Circ J; 2010 Nov; 74(12):2734-40. PubMed ID: 21041973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
    Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
    Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.
    Masson S; Agabiti N; Vago T; Miceli M; Mayer F; Letizia T; Wienhues-Thelen U; Mureddu GF; Davoli M; Boccanelli A; Latini R;
    J Intern Med; 2015 Mar; 277(3):318-330. PubMed ID: 24620922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Changes and Their Association with Fetuin-A and Fibroblast Growth Factor-23 in Children with Chronic Kidney Disease.
    Mudi A; Ntsinjana H; Dickens C; Levy C; Ballot D
    Nephron; 2017; 136(3):233-242. PubMed ID: 28402974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF23 and Phosphate-Cardiovascular Toxins in CKD.
    Vogt I; Haffner D; Leifheit-Nestler M
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31698866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fibroblast growth factor-23 (FGF-23). Part III. Relationship between FGF-23 serum concentration and cardio-vascular morbidity and mortality].
    Fedak D; Bigaj K; Sułowicz W
    Przegl Lek; 2011; 68(9):614-8. PubMed ID: 22335012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
    Khan AM; Chirinos JA; Litt H; Yang W; Rosas SE
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2017-22. PubMed ID: 22997345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.
    Nasrallah MM; El-Shehaby AR; Salem MM; Osman NA; El Sheikh E; Sharaf El Din UA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2679-85. PubMed ID: 20176609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease.
    Negri AL
    Int Urol Nephrol; 2014 Jan; 46(1):9-17. PubMed ID: 23296792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF-23 and cardiovascular disease: review of literature.
    Batra J; Buttar RS; Kaur P; Kreimerman J; Melamed ML
    Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):423-429. PubMed ID: 27652999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
    Isakova T; Xie H; Yang W; Xie D; Anderson AH; Scialla J; Wahl P; Gutiérrez OM; Steigerwalt S; He J; Schwartz S; Lo J; Ojo A; Sondheimer J; Hsu CY; Lash J; Leonard M; Kusek JW; Feldman HI; Wolf M;
    JAMA; 2011 Jun; 305(23):2432-9. PubMed ID: 21673295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship of brain natriuretic peptide to renal function and left ventricular hypertrophy in patients with chronic kidney disease].
    Zhou WY; Ni ZH; Gu LY; Fang W; Wang Q; Mou S; Cao LO; Yu ZZ; Qian JQ
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3284-7. PubMed ID: 18396626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study.
    Ix JH; Shlipak MG; Wassel CL; Whooley MA
    Nephrol Dial Transplant; 2010 Mar; 25(3):993-7. PubMed ID: 20037168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients.
    Sharma S; Joseph J; Chonchol M; Kaufman JS; Cheung AK; Rafeq Z; Smits G; Kendrick J;
    Clin Nephrol; 2013 Nov; 80(5):313-21. PubMed ID: 23849306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.
    Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ
    Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.